{"version":"1.0","type":"link","title":"Efficacy and safety of inotuzumab ozogamicin as the definitive therapeutic option prior to allogeneic hematopoietic stem cell transplantation for pediatric relapsed/refractory B-cell acute lymphoblastic leukemia.","author_name":"Hu GH 외","author_url":"https://prs-insight.online/author/Hu%20GH","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/161024","thumbnail_width":1200,"thumbnail_height":630}